SCHEMBL8285132

SCHEMBL8285132

COc1ccc(Nc2cc(=O)c3cc(F)c(Cl)nc3n2-c2ccc(OC)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.40
MAPK9 P45984 1/20 0.39
FLT3 P36888 4/20 0.38
EGFR P00533 1/20 0.38
MAPT P10636 5/20 0.37
CYP1A2 P05177 3/20 0.37
CYP3A4 P08684 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TSHR P16473 3/20 0.37
USP2 O75604 2/20 0.37
CYP2C9 P11712 1/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HTR2C P28335 1/20 0.37
MAPK1 P28482 2/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285115 0.88 BPTF (0.36) EGFRMAPTMEN1KMT2AALDH1A1
SCHEMBL8285126 0.88 PDE11A (0.36) FLT3EGFRMAPTMEN1KMT2A
SCHEMBL5872062 0.83 PDE11A (0.44) MAPTALDH1A1SMN1; SMN2MAPK1LMNA
SCHEMBL8287909 0.82 MAPT (0.44) MAPTCYP1A2MEN1KMT2AALDH1A1
SCHEMBL5871610 0.77 MEN1 (0.43) MAPK9FLT3EGFRMAPTCYP1A2
SCHEMBL8287325 0.77 GAA (0.42) MAPTCYP1A2CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL5872005 0.76 MAT2A (0.43) MAPK9CYP1A2CYP3A4MEN1KMT2A
SCHEMBL8287837 0.76 MAT2A (0.54) MAPK9MAPTCYP1A2CYP3A4MEN1
SCHEMBL8287801 0.75 ALDH1A2 (0.37) MAPTKMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL8286343 0.73 ADORA1 (0.43) MAPTSMN1; SMN2TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed